Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Hewitt

Showing results (91-100 of 94) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 94 results.
The Lancet. Public Health|July 4, 2020
The effect of frailty on survival in patients with COVID-19 (COPE): a multicentre, European, observational cohort studyJonathan Hewitt, Ben Carter, Arturo Vilches-Moraga, et al.
Therapeutic Advances in Drug Safety|March 8, 2021
Routine use of immunosuppressants is associated with mortality in hospitalised patients with COVID-19Phyo K Myint, Ben Carter, Fenella Barlow-Pay, et al.
Health Technology Assessment (Winchester, England)|April 11, 2025
Lessons from the PROTECT-CH COVID-19 platform trial in care homesPhilip M Bath, Jonathan Ball, Matthew Boyd, et al.
Trials|April 7, 2017
Reasons for non-recruitment of eligible patients to a randomised controlled trial of secondary prevention after intracerebral haemorrhage: observational studyAmy E Maxwell, Mary Joan MacLeod, Anu Joyson, et al.
Pageof 10

Showing results (91-100 of 94) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 94 results.
The Lancet. Public Health|July 4, 2020
The effect of frailty on survival in patients with COVID-19 (COPE): a multicentre, European, observational cohort studyJonathan Hewitt, Ben Carter, Arturo Vilches-Moraga, et al.
Therapeutic Advances in Drug Safety|March 8, 2021
Routine use of immunosuppressants is associated with mortality in hospitalised patients with COVID-19Phyo K Myint, Ben Carter, Fenella Barlow-Pay, et al.
Health Technology Assessment (Winchester, England)|April 11, 2025
Lessons from the PROTECT-CH COVID-19 platform trial in care homesPhilip M Bath, Jonathan Ball, Matthew Boyd, et al.
Trials|April 7, 2017
Reasons for non-recruitment of eligible patients to a randomised controlled trial of secondary prevention after intracerebral haemorrhage: observational studyAmy E Maxwell, Mary Joan MacLeod, Anu Joyson, et al.
Pageof 10